Literature DB >> 18451714

The prognosis of migraine.

Marcelo E Bigal1, Richard B Lipton.   

Abstract

PURPOSE OF THE REVIEW: The prognosis of migraine is poorly studied and research in this regard is in its infancy. Migraine is a chronic disorder with episodic attacks with a highly variable long-term prognosis. In many, migraine may have a very benign (complete remission) or relatively benign (partial remission) prognosis. In some, migraine persists and in others, it progresses. RECENT
FINDINGS: A recent population study showed that, over a 1-year period, 84% of the patients with migraine persisted with this diagnosis (migraine persistence); around 10% had 1-year complete clinical remission, and 3% had partial remission; the other 3% developed chronic migraine. Long-term studies support the concept that remission increases with age and also that risk factors for progression have been identified (e.g. medication overuse, obesity, etc.).
SUMMARY: Identifying predictors of migraine prognosis is, therefore, of great scientific and clinical interest. Herein we review the prognosis of migraine and risk factors for the above-mentioned nonexclusive possibilities.

Entities:  

Mesh:

Year:  2008        PMID: 18451714     DOI: 10.1097/WCO.0b013e328300c6f5

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  9 in total

Review 1.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 2.  Migraine is curable!

Authors:  R Allan Purdy
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

3.  Migraine chronification.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 4.  Neurobiology of migraine progression.

Authors:  Wanakorn Rattanawong; Alan Rapoport; Anan Srikiatkhachorn
Journal:  Neurobiol Pain       Date:  2022-06-09

Review 5.  Migraine and cardiovascular disease: possible mechanisms of interaction.

Authors:  M E Bigal; T Kurth; H Hu; N Santanello; R B Lipton
Journal:  Neurology       Date:  2009-05-26       Impact factor: 9.910

6.  [Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society].

Authors:  A Straube; C Gaul; S Förderreuther; P Kropp; M Marziniak; S Evers; W H Jost; H Göbel; C Lampl; P S Sándor; A R Gantenbein; H-C Diener
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

7.  Chronic migraine: treatability, refractoriness, pseudo-refractoriness.

Authors:  Piero Barbanti; Cinzia Aurilia; Gabriella Egeo; Luisa Fofi; Serena Piroso
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

8.  Endovascular thrombectomy and post-procedural headache.

Authors:  Sabrina Khan; Faisal Mohammad Amin; Markus Holtmannspötter; Klaus Hansen; Anna Maria Florescu; Zainab Fakhril-Din; Julie Falkenberg Petersen; Hashmat Ghanizada; Cenk Ayata; David Gaist; Messoud Ashina
Journal:  J Headache Pain       Date:  2017-01-28       Impact factor: 7.277

9.  Association of white matter hyperintensities with migraine features and prognosis.

Authors:  Hui Xie; Qiang Zhang; Kang Huo; Rui Liu; Zhi-Jie Jian; Yi-Tong Bian; Guo-Liang Li; Dan Zhu; Li-Hui Zhang; Jian Yang; Guo-Gang Luo
Journal:  BMC Neurol       Date:  2018-07-02       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.